World-class R&D leads to a right-first-time path to market
Center for Breakthrough Medicines (CBM) brings a breadth of expertise, technologies and R&D capabilities to our clients to rapidly develop patient therapies of the highest quality. Our comprehensive development and manufacturing services are located on a single site, and our technical team has experience working on the earliest cell and gene therapy programs, and has a history of progressing advanced therapies all the way to commercialization. CBM’s technology platforms are derived from our partnerships with the leading pioneers in the industry, and combine with our expertise and capabilities to deliver risk mitigation and the fastest path to market.
Accelerating progress and ensuring manufacturability
CBM can accelerate your program by providing diagnosis and solutions for your current vector design through a comprehensive capsid review and selection process to avoid future comparability studies. We assess manufacturability early on and recommend specific development actions to streamline scale-up and the regulatory process. We explore multiple approaches to increase yield, purity, and manufacturability. Our integrated process development enables a smooth tech transfer with the expected performance at manufacturing scale throughout the product lifecycle.
Cell line development and viral vector process development
CBM’s R&D services
Contact us to discuss how CBM’s integrated capabilities can support your program
Viral Vector Manufacturing
CBM’s viral vector capabilities efficiently and consistently delivers high yields in AAV, Lentivirus, HSV and Adenovirus vectors, accelerating the development of new therapies.
Cell Therapy Manufacturing
CBM has one of cell therapy’s most experienced teams and the largest single site facility in the industry. There is no greater centralization of expertise.
Our Experienced Team
Our team brings a wealth of experience from biopharma and advanced therapy CDMOs, ensuring that there is no safer place for your product.